221 related articles for article (PubMed ID: 24577622)
1. Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.
Berridge MJ
Cell Tissue Res; 2014 Aug; 357(2):477-92. PubMed ID: 24577622
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia.
Berridge MJ
Prion; 2013; 7(1):2-13. PubMed ID: 22895098
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of the genetic background of bipolar disorder and schizophrenia (introduction)].
Gábor G
Neuropsychopharmacol Hung; 2007 Jun; 9(2):77-9. PubMed ID: 17970530
[TBL] [Abstract][Full Text] [Related]
4. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models.
Kulak A; Steullet P; Cabungcal JH; Werge T; Ingason A; Cuenod M; Do KQ
Antioxid Redox Signal; 2013 Apr; 18(12):1428-43. PubMed ID: 22938092
[TBL] [Abstract][Full Text] [Related]
5. Calcium as a Trojan horse in mental diseases-The role of PMCA and PMCA-interacting proteins in bipolar disorder and schizophrenia.
Lisek M; Boczek T; Zylinska L
Neurosci Lett; 2018 Jan; 663():48-54. PubMed ID: 28780170
[TBL] [Abstract][Full Text] [Related]
6. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
Gray LJ; Dean B; Kronsbein HC; Robinson PJ; Scarr E
Psychiatry Res; 2010 Jul; 178(2):374-80. PubMed ID: 20488553
[TBL] [Abstract][Full Text] [Related]
7. The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.
Goto Y; Grace AA
Int Rev Neurobiol; 2007; 78():41-68. PubMed ID: 17349857
[TBL] [Abstract][Full Text] [Related]
8. Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts.
Altar CA; Jurata LW; Charles V; Lemire A; Liu P; Bukhman Y; Young TA; Bullard J; Yokoe H; Webster MJ; Knable MB; Brockman JA
Biol Psychiatry; 2005 Jul; 58(2):85-96. PubMed ID: 16038679
[TBL] [Abstract][Full Text] [Related]
9. Protein Translation and Psychiatric Disorders.
Laguesse S; Ron D
Neuroscientist; 2020 Feb; 26(1):21-42. PubMed ID: 31271100
[TBL] [Abstract][Full Text] [Related]
10. Calcium ions in neuronal degeneration.
Wojda U; Salinska E; Kuznicki J
IUBMB Life; 2008 Sep; 60(9):575-90. PubMed ID: 18478527
[TBL] [Abstract][Full Text] [Related]
11. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
[TBL] [Abstract][Full Text] [Related]
12. Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.
Lin CY; Sawa A; Jaaro-Peled H
Neurobiol Dis; 2012 Jan; 45(1):48-56. PubMed ID: 21914480
[TBL] [Abstract][Full Text] [Related]
13. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.
Zhan L; Kerr JR; Lafuente MJ; Maclean A; Chibalina MV; Liu B; Burke B; Bevan S; Nasir J
Neuropathol Appl Neurobiol; 2011 Feb; 37(2):206-19. PubMed ID: 20874815
[TBL] [Abstract][Full Text] [Related]
14. Decreased thalamic expression of the homeobox gene DLX1 in psychosis.
Kromkamp M; Uylings HB; Smidt MP; Hellemons AJ; Burbach JP; Kahn RS
Arch Gen Psychiatry; 2003 Sep; 60(9):869-74. PubMed ID: 12963668
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder.
Clinton SM; Meador-Woodruff JH
Neuropsychopharmacology; 2004 Jul; 29(7):1353-62. PubMed ID: 15054476
[TBL] [Abstract][Full Text] [Related]
16. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder.
Benes FM; Berretta S
Neuropsychopharmacology; 2001 Jul; 25(1):1-27. PubMed ID: 11377916
[TBL] [Abstract][Full Text] [Related]
17. Is 'bipolar disorder' the brain's autopoietic response to schizophrenia?
Llewellyn S
Med Hypotheses; 2009 Oct; 73(4):580-4. PubMed ID: 19589644
[TBL] [Abstract][Full Text] [Related]
18. In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia.
Bojarski L; Debowska K; Wojda U
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Dec; 34(8):1367-74. PubMed ID: 20813148
[TBL] [Abstract][Full Text] [Related]
19. Genetic variations of human neuropsin gene and psychiatric disorders: polymorphism screening and possible association with bipolar disorder and cognitive functions.
Izumi A; Iijima Y; Noguchi H; Numakawa T; Okada T; Hori H; Kato T; Tatsumi M; Kosuga A; Kamijima K; Asada T; Arima K; Saitoh O; Shiosaka S; Kunugi H
Neuropsychopharmacology; 2008 Dec; 33(13):3237-45. PubMed ID: 18354391
[TBL] [Abstract][Full Text] [Related]
20. Expression of neuronal calcium sensor-1 (NCS-1) is decreased in leukocytes of schizophrenia and bipolar disorder patients.
Torres KC; Souza BR; Miranda DM; Sampaio AM; Nicolato R; Neves FS; Barros AG; Dutra WO; Gollob KJ; Correa H; Romano-Silva MA
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):229-34. PubMed ID: 19091302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
